Empowering Small Businesses
Sommer Gay Launch Marketing is a results-driven firm helps event and hospitality businesses nationwide amplify their brand, drive traffic, and convert leads. Launch Marketing has a strong bench of talented creatives and data analysts who revel in nerding out over numbers, words and design. The launchpad for event and hospitality brands. SOMMER GAY PHARMD
About SOMMER GAY This page provides the complete NPI Profile along with additional information for Sommer Gay, a provider established in Seattle, Washington with a medical specialization in Pharmacist, focusing in oncology. The healthcare provider is registered in the NPI registry with number assigned on October Records indicate that the provider gender is "Female". Phone: Fax:.
She’s in Business! From Idea to Impact with Sommer Gay
Sommer Gay is a PGY2 Oncology Pharmacy Resident at Froedtert Hospital in Milwaukee, Wis. The complete NPI record is also available for download in text, csv and xml formats. The NPI is a digit identification number that is completely unique.
SOMMER GAY PHARMD NPI 1508687591
View Sommer Gay, PharmD, BCOP’s profile on LinkedIn, a professional community of 1 billion members. .
Tim Kruger's TimTales (TV Series 2009– )
Welcome to Sommer Gay and Daniel Kertzman's Wedding site! View photos, directions, registry details and more at The Knot. .
Sommer Gay
Meet the Team: Sommer Gay The launchpad for event and hospitality brands. We are encouraging, transparent, supportive, and active! Mission Our mission is to EDUCATE small businesses on how to successfully navigate the digital marketing landscape. . SOMMER GAY, PHARM.D., Oncology SEATTLE, WA
Sommer Gay is on Facebook. Join Facebook to connect with Sommer Gay and others you may know. Facebook gives people the power to share and makes the world more open and connected. .
Sommer Gay
SOMMER GAY, PHARM.D. – NPI # Oncology NPI Profile for SOMMER GAY in SEATTLE, WA. A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. .